Episode

Safety and Efficacy of Satralizumab in Patients with Relapsing MOGAD

Podcast
Neurology® Podcast
Published
Jun 22, 2026
Duration seconds
750
Processing state
not_requested
Canonical source
https://neurology.libsyn.com/safety-and-efficacy-of-satralizumab-in-patients-with-relapsing-mogad
Audio
https://traffic.libsyn.com/secure/neurology/Neurology_Podcast_June_23rd_2026_v3.mp3?dest-id=937793
JSON
/v1/public/podcasts/neurology-podcast-635512/episodes/safety-and-efficacy-of-satralizumab-in-patients-with-relapsing-mogad
Markdown
/podcast/neurology-podcast-635512/safety-and-efficacy-of-satralizumab-in-patients-with-relapsing-mogad.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/neurology-podcast-635512/episodes/safety-and-efficacy-of-satralizumab-in-patients-with-relapsing-mogad/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/neurology-podcast-635512/safety-and-efficacy-of-satralizumab-in-patients-with-relapsing-mogad.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Dr. Shuvro Roy talks with Dr. Michael Levy about satralizumab for treating relapsing MOGAD, current management challenges, and the encouraging results of this new therapy. Read more about this abstract . Disclosures can be found at Neurology.org .